CRISPR-based genome editing in primary human pancreatic islet cells
The editing of primary human islets could provide insight into diabetes pathogenesis. Here the authors use CRISPR-Cas9 to target regulatory elements associated with T2D susceptibility.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/22d2b0339efc4aa29c30bb51db113c85 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|